Award

Development of Technologies for Efficient In Vivo Prime Editing

Description: NARRATIVE Genome editing technologies provide novel opportunities to advance basic research and treat human diseases but approaches that use active nucleases to edit DNA can induce undesired and deleterious effects in the genome, which can reduce their therapeutic potential. Prime editors are a recently emerged gene-editing variant capable of introducing precise modifications to DNA, with minimal damage to the genome. This proposal is focused on creating an integrative prime editing toolkit that will provide investigators with technologies that will enable their use in vivo, improve their specificity and streamline their design and implementation, thereby advancing the applications of this methodology in biotechnology and biomedicine.
Funding type: research
Funder scheme: R01
Start date: 2021-04-01
End date: 2026-02-28
Institutions: University of Illinois Urbana-Champaign, UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
Funded outputs count: 12
Funder award ID: R01GM141296
OpenAlex ID: G7635306544
2026 · Shraddha Shirguppe, Michael Gapinske, et al. · Nature Biomedical Engineering · 11
2026 · Katherine Tan, Daniela Del Bosque Siller, et al. · Molecular Therapy · 8
2025 · Tristan X. McCallister, Colin K. W. Lim, et al. · Nature Communications · 19
2024 · Angelo Miskalis, Shraddha Shirguppe, et al. · Nature Communications · 13
2023 · Jackson Winter, Shraddha Shirguppe, et al. · Current Opinion in Biomedical Engineering · 6
2023 · M. Alejandra Zeballos C., Hayden J. Moore, et al. · Nature Communications · 37
2023 · Michael Gapinske, Jackson Winter, et al. · Molecular Therapy — Nucleic Acids · 19
2023 · Somang Kim, Jimmy B. Yuan, et al. · Frontiers in Genetics · 14
2023 · Nicholas O. Stevers, Somang Kim, et al. · Molecular Cell · 7
2023 · Colin K. W. Lim, Angelo J. Miskalis, et al. · Methods in molecular biology · 2
2022 · Colin K.W. Lim, Tristan X. McCallister, et al. · Molecular Therapy · 28
2022 · Jackson E. Powell, Colin K. W. Lim, et al. · Science Advances · 101